Pim-1/2 Kinase Inhibitor 1 is an orally bioavailable small molecule that blocks Pim kinase activity, specifically inhibiting the phosphorylation of substrates like 4E-BP1 and p27 Kip1. It is a valuable research tool for studying oncogenic signaling in cancers such as prostate cancer, with applications in both in vitro and in vivo experimental models.
